Advertisement

Il versamento pleurico: aspetti eziologici, diagnostici e clinici

  • Lina Zuccatosta
Chapter
  • 509 Downloads

Estratto

Il coinvolgimento della pleura puÒ comparire nel corso di molteplici e differenti patologie. Le cause che sottendono un versamento pleurico possono essere intra-toraciche o sistemiche e, se in alcuni casi queste appaiono facilmente individuabili grazie a segni clinici patognomonici, in altri casi l’inquadramento nosografico di un versamento puÒ risultare complesso, dovendosi basare su elementi clinici e reperti laboratoristico-strumentali spesso aspecifici.

Bibliografia

  1. 1.
    Light RW (1990) Approach to the patient. In: Light RW (ed) Pleural diseases. Lea & Febiger, Philadelphia, pp 75–84Google Scholar
  2. 2.
    Valdes L, Alvarez D, Valle JM et al (1996) The etiology of pleural effusion in an area with high incidence of tuberculosis. Chest 109:158–162PubMedCrossRefGoogle Scholar
  3. 3.
    Burgess LJ, Maritz FJ, Taljaard JJ (1996) Epidemiology of pleural effusion. S Afr Med J 86:186PubMedGoogle Scholar
  4. 4.
    Marel M, Zrustova M, Stastny B, Light RW (1993) The incidence of pleural effusion in a well-defined region. Epidemiologic study in Central Boemia. Chest 104:1486–1489PubMedCrossRefGoogle Scholar
  5. 5.
    Andrews CO, Gora M (1994) Pleural effusions: pathophysiology and management. Ann Pharmacother 28:894–903PubMedGoogle Scholar
  6. 6.
    Light RW (1997) Diagnostic principles in pleural disease. Eur Respir J 10:476–481PubMedCrossRefGoogle Scholar
  7. 7.
    Antony VB, Loddenkemper R, Astoul P et al (2000) Management of malignant pleural effusions. Am J Respir Crit Care Med 162:1987–2001Google Scholar
  8. 8.
    Kennedy L, Sahn SA (1994) Noninvasive evaluation of the patient with a pleural effusion. Chest Surg Clin N Am 4:451–465PubMedGoogle Scholar
  9. 9.
    Light RW (2001) Pleural effusion due to pulmonary emboli. Curr Opin Pulm Med 7:198–201PubMedCrossRefGoogle Scholar
  10. 10.
    Blackmore CC, Black WC, Dallas RV et al (1996) Pleural fluid volume estimation. A chest radiograph prediction rule. Acad Radiol 3:103–109PubMedCrossRefGoogle Scholar
  11. 11.
    Weiss JM, Spodick DH (1984) Laterality of pleural effusion in chronic congestive heart failure. Am J Cardiol 53:951PubMedCrossRefGoogle Scholar
  12. 12.
    Fraser RG, Pare JAP, Freser RS et al (1988). In: Diagnosis of diseases of the chest. Volume IV, 3‡ ed. WB Saunders Company, PhiladelphiaGoogle Scholar
  13. 13.
    McLoud TC (1988) CT and MR in pleural disease. Clin Chest Med 19:261–278CrossRefGoogle Scholar
  14. 14.
    Traill ZC, Davies RJO, Gleeson FV (2001) Thoracic computed tomography in patients with suspected malignant pleural effusion. Clin Radiol 56:193–196PubMedCrossRefGoogle Scholar
  15. 15.
    Kohan JM, Poe RH, Israel RH et al (1992) Value of chest ultrasonography in determining the nature of pleural effusion. Analysis of 320 cases. AJR Am J Roentgenol 159:29–33Google Scholar
  16. 16.
    Hierholzer J, Luo L, Bittner RC et al (2000) MRI and CT in the differential diagnosis of pleural disease. Chest 118:604–609PubMedCrossRefGoogle Scholar
  17. 17.
    Erasmus JJ, McAdams HP, Rosso SE et al (2000) FDG-PET of pleural effusions in patients with non-small cell lung cancer. AJR Am J Roentgenol 175:245–249PubMedGoogle Scholar
  18. 18.
    Gupta N, Rogers JS, Graeber GM et al (2002) Clinical role of F-18 fluorodeoxiglucose positron emission tomography imaging in patients with lung cancer and suspected malignant pleural effusion. Chest 122:1918–1924PubMedCrossRefGoogle Scholar
  19. 19.
    Sahn SA (1988) State ofthe art. The pleura. Am Rev Respir Dis 138:184–234PubMedGoogle Scholar
  20. 20.
    Mattison LE, Coppage L, Alderman DF et al (1997) Pleural effusions in the medical ICU:prevalence,causes and clinical implications. Chest 111:1018–1023PubMedCrossRefGoogle Scholar
  21. 21.
    Mayo PH, Goltz HR, Trafeshi M et al (2004) Safety of ultrasound-guided thoracentesis in patients receiving mechanical ventilation. Chest 125:1059–1062PubMedCrossRefGoogle Scholar
  22. 22.
    Bartter T, Santarelli R, Akes SM et al (1995) The evaluation of pleural effusion. Chest 107:592Google Scholar
  23. 23.
    Maskell NA, Butland RJ (2003) BTS guidelines for the investigation of a unilateral pleural effusion in adults. Thorax 58:ii8PubMedGoogle Scholar
  24. 24.
    Light RW, Macgregor MI, Luchsinger PC (1972) Pleural effusions:the diagnostic separation of trasudates and exudates. Ann Intern Med 77:507–513PubMedGoogle Scholar
  25. 25.
    Hamm H, Brohan U, Missmahl HP (1987) Cholesterol in pleural effusions. A diagnostic aid. Chest 92:269–302CrossRefGoogle Scholar
  26. 26.
    Heffner JE, Sahn SA, Brown LK (2002) Multilevel likelihood ratios for identifyng exudative pleural effusions. Chest 121:1916–1920PubMedCrossRefGoogle Scholar
  27. 27.
    Sherr HP, Light RW, Merson MH et al. (1972) Origin of pleural fluid amylase in esophageal rupture. Ann inter Med 76:985–986Google Scholar
  28. 28.
    Kramer M (1989) High amylase levels in neoplasm-related pleural effusion. Ann Inter Med 110:567–569Google Scholar
  29. 29.
    Foresti V, Villa A, Zubani R (1994) Amylase concentrations in pleural effusion. Chest 105:1625–1626PubMedGoogle Scholar
  30. 30.
    Villena V, Perez V, Pozo F et al (2002) Amylase level in pleural effusion. Chest 121:470–474PubMedCrossRefGoogle Scholar
  31. 31.
    Rodriguez P, Lopez M (1989) Low glucose and pH levels in malignat pleural effusions. Diagnostic significance and prognostic value in respect to pleurodesis. Am Rev Respir Dis 139:663–667Google Scholar
  32. 32.
    Sahn SA, Good JTJ (1988) Pleural fluid pH in malignant effusions. Diagnostic, prognostic and therapeutic implications. Ann Inter Med 108:345–349Google Scholar
  33. 33.
    Heffner JE, Heffner JN, Brown LK (2003) Multilevel and continuous pleural fluid pH likelihood ratios for evaluating malignant pleural effusions. Chest 123:1887–1894PubMedCrossRefGoogle Scholar
  34. 34.
    Light RW, Ball WCJ (1973) Glucose and amylase in pleural effusion. JAMA 225:257–259PubMedCrossRefGoogle Scholar
  35. 35.
    Hillerdal G (1997) Chylothorax and pseudochylothorax. Eur Respir J; 10:1150–1156CrossRefGoogle Scholar
  36. 36.
    Hillerdal G (1985) Chyliform (cholesterol) pleural effusion. 88;426–428Google Scholar
  37. 37.
    Light RW, Erozan YS, Ball WCJ (1973) Cells in pleural fluid.Their value in differential diagnosis. Arch Inter Med 132:854–860CrossRefGoogle Scholar
  38. 38.
    Light RW (1995) Pleural diseases, 3rd ed. William and Wilkins, BaltimoreGoogle Scholar
  39. 39.
    Martinez-Garcia MA, Cases-Viedma E, Corsero-Rodriguez PJ et al (2000) Diagnostic utility of eosinophils in the pleural fluid. Eur Respir J 15:1666–1669CrossRefGoogle Scholar
  40. 40.
    Rubins JB, Rubins HB (1996) Aetiology and prognostic significance of eosinophilic pleural effusion. A prospective study. Chest 110:1271–1274PubMedCrossRefGoogle Scholar
  41. 41.
    Loddenkemper R, Grosser H, Serke M (1983) Prospective evaluation of biopsy methods in the diagnosis of malignant pleural effusions: intrapatient comparison between pleural fluid cytology,fine needle biopsyand thoracoscopy. Am Rev Respir Dis 127[Suppl 4]:114Google Scholar
  42. 42.
    Garcia L (1994) The value of multiple fluid specimens in the cytological diagnosis of malignancy. Mod Pathol 7:665–668PubMedGoogle Scholar
  43. 43.
    Dejmek A, Hjerpe A (2000) Reactivity of six antibodies in effusions of mesothelioma, adenocarcinoma and mesotheliosis: stepwise logistic regression analysis. Cytopatology 11:8–17CrossRefGoogle Scholar
  44. 44.
    Alfagame I, Munoz F, Pena N et al (1993) Empyema of the thorax in adult. Etiology, microbiologic findings and management. Chest 103:839–843CrossRefGoogle Scholar
  45. 45.
    Barnes TW, Olson EJ, Morgenthaler TI et al (2005) Low yield of microbiologic studies on pleural fluid specimens. Chest 127:916–921PubMedCrossRefGoogle Scholar
  46. 46.
    Frank W (2002) Tuberculous pleural effusion. Eur Respir Mon 22:219–233Google Scholar
  47. 47.
    Burgess LJ, Maritz FJ, Le Roux I et al (1996) Combined use of pleural adenosine-deaminase with lymphocyte/neutrophil ratio: increased specificity for the diagnosis of tuberculous pleuritis. Chest 109:414–419PubMedCrossRefGoogle Scholar
  48. 48.
    Goto M, Noguchi Y (2003) Diagnostic value of adenosine-deaminasi in tuberculous pleural effusion:a meta-analysis. Ann Clin Biochem 40:374–381PubMedCrossRefGoogle Scholar
  49. 49.
    Laborin RL (2005) Adenosine-deaminase in the diagnosis of tuberculous pleural effusion. Editorial. Chest 127:417–418Google Scholar
  50. 50.
    Haraki H, Aoe K, Eda R et al (2004) Comparison of six biological markers for the diagnosis of tuberculous pleuritis. Chest 125:987–989CrossRefGoogle Scholar
  51. 51.
    Villena V, Lopez-Encuentra A, Echave-Sustaeta J et al (2003) Diagnostic value of CA 549 in pleural fluid: comparison with CEA, CA 15-3 and CA 72-4. Lung Cancer 40:289–294PubMedGoogle Scholar
  52. 52.
    Porcel JM, Vives M, Esquerda A et al (2004) Use of panel of tumor markers in pleural fluid for the differential diagnosis of benign and malignant effusions. Chest 126:1757–1763PubMedCrossRefGoogle Scholar

Copyright information

© Springer Verlag Italia 2007

Authors and Affiliations

  • Lina Zuccatosta
    • 1
  1. 1.Divisione di PneumologiaAzienda Ospedaliero-Universitaria Ospedali RiunitiAncona

Personalised recommendations